Munguva pfupi yapfuura, National Medical Products Administration (NMPA) yeChina yakabvumidza Enhertu kuti ibayiwe jekiseni rekurapa mhando dzakasiyana dzevarwere vane kenza yemazamu yakakwira, zvichiratidza kufambira mberi kukuru mukurwisa kenza yemazamu pasi rose. Kubvumidzwa uku kwakavakirwa pamhedzisiro yakanaka yekuyedzwa kwekiriniki yeDESTINY-Breast06, zvichiratidza kubudirira kwekurapa kwakanangana ne hormone receptor-positive,
Musi wa25 Zvita, 2025, NMPA yakabvumidza zviri pamutemo Enhertu yekurapa varwere vakuru vane kenza yemazamu vasingarapike kana kuti vane hormone receptor-positive, HER2-low kana ultra-low expression avo vakafambira mberi mushure mekurapwa kwe endocrine kare munzvimbo yakapararira. Purofesa Hu Xichun, Chief Expert weDhipatimendi reMishonga Yemukati paFudan University Shanghai Cancer Center, akati: "Mhedzisiro yechidzidzo cheDESTINY-Breast06 inopa humbowo hwekutanga hwekuti kurapwa kwakanyatsojeka kunogona kubatsira varwere ava vaisambotarisirwa zvakakwana, izvo zvine kukosha kukuru kwesainzi. Nekubvumidzwa uku, varwere vakawanda vane HR-positive vane HER2 expression vachawana mukana wekubatsirwa neADC drug therapy."
Ruzivo rwekuyedzwa kwekiriniki runokurudzira: kune varwere vane HR-positive, HER2-low metastatic cancer avo vakanga vasati vambowana chemotherapy kare, Enhertu yakaderedza njodzi yekufambira mberi kwechirwere kana kufa ne38% zvichienzaniswa nechemotherapy. Chinonyanya kukosha ndechekuti, mwero wemhinduro chaiyo wakasvika 56.5% muvarwere vane HER2-low uye kunyange kusvika 61.8% muhuwandu hwevanhu vane HER2 ultra-low expression, zvose zviri zviviri zvakakwirira zvakanyanya kupfuura muboka rechemotherapy.
Dhipatimendi reInternational Hospital Oncology reBeijing South Region: Kubatanidza Varwere Vepasi Pose neKurapwa Kwepamusoro
Seimwe yenzvimbo dzakakosha dzekurapa kenza muChina, Dhipatimendi reBeijing South Region Oncology Hospital International rakatsaurira kupa varwere vepasi rose nzira dzepamusoro dzekurapa kenza uye mabasa ekurapa akagadzirirwa ivo pachavo. Tinonyatsotevera kufambira mberi kwekurapa kwenyika dzese kuitira kuti varwere vagone kuwana mishonga yazvino inotenderwa nekukurumidza.
Chikwata chedu chekurapa chepasi rose chine nyanzvi dzekurapa kenza dzine ruzivo kwete chete muhunyanzvi hwemazuva ano hwekurapa asiwo vane hunyanzvi hwekutaurirana mumitauro yakawanda, zvichivabatsira kupa rutsigiro rwakakwana rwekurapa uye masevhisi kuvarwere vekune dzimwe nyika.
Nzira Dzakanakira Kutaurirana: Nzira Dzakawanda Dzekutaurirana
Tinonzwisisa zvinodiwa nekukurumidza nevarwere vekune dzimwe nyika vari kutsvaga rubatsiro rwezvekurapa, saka tinopa nzira dzakasiyana-siyana dzekutaurirana nadzo:
Kubvunzana Nefoni: Ndapota fonerai nhamba yedu yepasi rose yekubatsira varwere panhamba 400-880-3716. Varongi vedu vezvehutano vane hunyanzvi vachakupai mazano akadzama uye gwara.
Kutaurirana neWeChat: Wedzera account yedu yepamutemo yeWeChat panhamba 17801183037 kuti utaure zvakananga nemupi wezano wezvekurapa kuburikidza nemeseji, izwi, kana vhidhiyo.
Tsamba yemagetsi:
- Send inquiries to 100085_010@163.com
- Or contact myimmnet@163.com
Chikwata chedu chichapindura email yenyu mukati memaawa makumi maviri nemana, chichikupai ruzivo rwakadzama rwekurapwa, kutanga kuchipatara, kusangana nenyanzvi, nemamwe mabasa.
Mabasa Akakwana Evarwere Vepasi Pose
Dhipatimendi reBeijing South Region Oncology Hospital International rinopa rubatsiro rwekusvika kune varwere vekune dzimwe nyika, kusanganisira:
- Kubvunzana kwenyanzvi uye kubvunzana kuri kure
- Kuongororwa kwehurongwa hwekurapa uye kuumbwa kwahwo
- Marongero ekurara muchipatara uye rutsigiro rwevhiza yekurapa
- Rubatsiro rwekushandura mutauro uye kugadzirisa tsika
- Nhungamiro pamusoro pekugara panguva yekurapwa
Tinonzwisisa zvakadzama kuti rwendo rwemurwere wega wega rwakasiyana. Saka, takazvipira kupa rubatsiro rwehutano rwakagadzirirwa iwe pachako uye hune hunhu kuitira kuti uve nechokwadi chekuti unonzwa kutarisirwa kwehunyanzvi uye rutsigiro panguva yekurapwa kwako.
Tora Matanho: Wana Mazano Ekurapwa Akakodzera Iwe
Kana iwe kana vadikanwi vako muri kusangana nematambudziko mukurapwa kwegomarara remazamu, kunyanya gomarara remazamu remhando dzeHR-positive, HER2-low kana ultra-low expression, ino ndiyo nguva yekutsvaga mazano echiremba ane hunyanzvi. Kubvumidzwa kweEnhertu kunounza tariro itsva kuboka iri revarwere.
Tibatei nekukasika muchishandisa nzira dzinotevera:
- Fonera 400-880-3716 kuti utaure zvakananga nemupi wezano wezvekurapa
- Wedzera WeChat 17801183037 kuti muwane mazano ipapo ipapo
- Send an email to 100085_010@163.com or myimmnet@163.com with a detailed description of the condition
Chikwata chedu chezvekurapa chepasi rose chichakupa mazano ekurapa kwehunyanzvi uye kuronga zvichienderana nemamiriro ako chaiwo. KuBeijing South Region Oncology Hospital International Department, tinotenda kuti murwere wese anofanirwa kuwana kurapwa kwepamusoro uye kwakakodzera. Tinotarisira kukubatsira munzira yekupora.
Nguva yekutumira: Ndira-08-2026